Annual report for Aarti Drugs Ltd. for FY-2023
30-04-2023
AARTI DRUGS LTD. - 524348 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions for the half year ended March 31, 2023.29-04-2023
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of Statutory Auditor29-04-2023
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Financial Results for the quarter and year ended March 31, 202329-04-2023
AARTI DRUGS LTD. - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2023
Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 202329-04-2023
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Quarterly Conference Call for the Investors and Analysts27-04-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201524-04-2023
AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Audited Financial Results
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2023 ,inter alia, to consider and approve Audited Financial Results for the Quarter and year ended March 31, 202323-04-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201515-04-2023
AARTI DRUGS LTD. - 524348 - Certificate As Per Regulation 40(9) And 40(10) Of The SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2023
Certificate as per Regulation 40(9) and 40(10) of the SEBI (LODR) Regulations, 2015 for the Financial Year ended March 31, 202315-04-2023